Click on the thumbnail below to read more on our faculty members
He has been working intensively with the European Society of Cardiology (ESC), and is currently serving as President of the ESC. He has been Associate Editor of the American College Cardiology, and is currently Associate Editor of the European Heart Journal. He has co-authored numerous scientific articles, has guided many PhD fellows and his main interests of research include imaging in heart failure, stable coronary artery disease, valvular heart disease and atrial fibrillation.
He received his MB, ChB, from the University of Cape Town and his D.Phil degree from Oxford University where he was a Rhodes Scholar. He received the degree of Ph.D. (honoris causa) from The University of Coimbra, Portugal in 2005. Dr
He has 1175 publications (1027 manuscripts and 148 book chapters) (h-index 132). He was named in the Thomson Reuters list of individuals with the greatest number of cited scientific papers 2002-2012. Dr. Gersh is the editor of 15 books and on the editorial board of 27 journals, including The European Heart Journal (Deputy Editor) He is Editor-in-Chief of UpToDate in Cardiology.
He has received Teacher of the Year Awards from the Division of Cardiovascular Diseases Mayo Clinic and numerous Visiting Professorships and Invited Lectures both nationally and internationally. He is an Honorary /\Fellow of multiple international societies, an Honorary Professor of Medicine at the University of Cape Town, and an Adjunct Professor of Medicine at Duke University Please add an Honorary Professor at the University of London.
Dr. Gersh was the 2004 recipient of the Distinguished Achievement Award of the AHA Council of Clinical Cardiology and the 2007 recipient of the ACC Distinguished Service Award. , the Hatter Award for “Advancement in the Cardiovascular Science” from University College London and the University of Cape Town 2009 and 2016 Dr. Gersh is the recipient of the 2012 James B. Herrick award of the AHA and the Distinguished Scientist Award of the AHA in 2016., and in 2013 he was designated Master of the American College of Cardiology. At ESC in 2013 he was designated as one of four “legends of modern cardiology” and in 2010 and 2016 he received the Silver and Gold Medals of the European Society of Cardiology. Dr. Gersh is the 2015 recipient of the Mayo Clinic Distinguished Alumni Award.
Dr. Birkemeyer graduated from medical school at Justus-Liebig-University Gießen. He completed a two-year research scholarship as undergraduate which was funded by the German Scholarship Foundation.
After specialist training in internal medicine, cardiology and intensive care medicine he became deputy head of cardiology at the Schwarzwald Baar Klinikum, where he set up a comprehensive interventional service and regional primary PCI network.
In 2011 he joined the structural heart team at the University Hospital of Rostock. In 2014 he became partner at the Herzklinik Ulm and joined the structural heart team at the University Hospital of Ulm where he is also an Associate Professor of Cardiology.
His main research interests are primary PCI and coronary device development. Dr. Birkemeyer has been involved in more than 40 cardiology trials and has published more than 60 peer-reviewed manuscripts and book chapters. He is a member of several professional associations, including the European Society of Cardiology (ESC), Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology, German Cardiac Society (DGK) and the Working Group Interventional Cardiology (AGIK) of the German Cardiac Society.
François Carré, MD - PhD, is Professor of Cardiovascular Physiology and Muscular Exercise at the University of Rennes 1 (France). François is a Cardiologist and the head of the Department of Sports Medicine at the Pontchaillou Hospital of Rennes, assistant director of the Inserm U1099 research unit and former secretary of the sport's cardiology section of the European Cardiology Society (ESC). His research focuses on cardiovascular responses and adaptations to physical training by athletes. In this context he published several articles on the ethnic specificities of athlete's heart. Runner, he participates regularly for the pleasure to long-distance events on road or in trail.
She is the Lead of the Myocardial Theme of the Oxford BHF Centre of Excellence and of the Cardiovascular Theme of the National Institute for Health Research Biomedical Research Centre.
Professor Casadei graduated in Medicine (cum Laude & Gold Medal) at the University of Pavia, Italy and moved to Oxford in 1989 to undertake her clinical and research training. She was awarded the Joan and Richard Doll Fellowship at Green College in 1991, a DPhil in Cardiovascular Medicine in 1995, and a BHF Senior Research Fellowship in 2001.
Professor Casadei is a Fellow of the UK Academy of Medical Sciences and the current President of the European Society of Cardiology (ESC).
Professor Casadei provides a clinical service at the Oxford University Hospitals NHS Trust’s John Radcliffe Hospital and leads a bench-to-bedside translational research programme, which spans from clinical trials to bench-based investigation in human tissue and cells with a focus on atrial fibrillation.
Dr Taweesak Chotivatanapong is now The Chairman of International Academic Institute Program and Senior Consultant at Central Chest Institute of Thailand.
He is now also serving as a PCU Director of Cardiovascular Surgery of Bangkok Heart Hospital, BDMS Hospital Network, Bangkok, Thailand. He is a councillor member of the ASCVTS, active member of AATS and International Fellow Member of STS and ANZSCTS.
During the last several years, he set up the Heart Care Foundation that he serves as the President of the foundation. The main activities of this foundation are to provide operations for valvular heart patients in the long waiting list and training for young surgeons under "Train the Trainer" program throughout Thailand and the region. Several Centre of Excellence for valve repair is now successfully established under this program.
He also serves as Chairman COE of National Cardiovascular and Thoracic Disease Ministry of Public Health. After received his training for CVT surgery in Thailand, he got his further training in Australia and the USA. He is the immediate Past President of Society of Thoracic Surgeons of Thailand.
Most of his research focused on Mitral Valve Repair, Ross operation for infective AV and especially in Rheumatic Valve Repair.
She has trained in Germany, Zimbabwe and the United Kingdom and has published and educated internationally. She is currently the lead for cardiovascular imaging audit and governance at the Barts Heart Centre, in London, with a clinical through-put of 9000 CMR and 7000 cardiac CT scans per year. Anna contributes energetically to the international CMR community as a member of the SCMR outreach committee and Rapid CMR (www.rapidcmr.com).
Anna remains actively involved in research and maintains a keen interest in acute clinical and obstetric cardiology at the Royal Free Hospital, London.
Dr Grace Lin is a Consultant Cardiologist and Associate Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. She completed her residency in Internal Medicine and Cardiology training at the Mayo Clinic and subsequently joined the faculty. Dr Lin specializes in echocardiography and Advanced Heart Failure and is currently the Director of Heart Failure Services at Mayo Clinic and a member of the American College of Cardiology Heart failure and Transplant Council. She is a member of the Mayo Echo Core Laboratory, which provides echocardiographic analysis for both national and international clinical trials. Her research and clinical interests are in imaging for heart failure and arrhythmias, cardiac amyloidosis and cardio-oncology. Dr Lin also directs the expansion of the Mayo Clinic Tutorials series, which creates enduring materials for both continuing medical education and fellows in training.
Dr Marie-Claude Morice studied at the University of Medicine in Paris where she obtained her medical degree in 1973 and her Diploma in Specialized Cardiology Studies in 1975. In 1986, she was appointed Head of the Interventional Cardiology Department of the CCN, the 2nd largest PCI center in France in 1990.
Since 1995, she has been the Head of Interventional Cardiology at the Institut Cardiovasculaire Paris (Générale de Santé) the highest-volume PCI centers in the Greater Paris Area.
Dr Morice is a Fellow of the European Society of Cardiology and the American College of Cardiology and Honorary Professor of the Universidad Del Salvador in Buenos Aires.
She is regularly invited as a guest lecturer and chairperson at all major international Cardiology scientific sessions of the AHA, ACC and ESC as well as guest faculty and live case operator in all prominent Interventional Cardiology courses (TCT, TCTAP, TOPIC, CIT, SUMMIT, EuroPCR) in Europe, North and South America and Asia and a board member and Senior Consulting Adviser of EuroPCR. She is a co-editor for EuroIntervention and an invited reviewer for the Lancet, the NEJM, JAMA, Circulation, JACC, EHJ and others.
Dr Morice has been involved in multiple clinical research activities over the past 20 years resulting in more than 250 peer-reviewed publications. She was voted Best Clinical Researcher in 1995 (Erasmus) and Cardiologist of the year in 1997. She was the co-founder of the French study group ‘Coronary Stenting Without Coumadin’, the Principal Investigator of the Ravel Trial, the Reality Study and the co PI of the Syntax Trial in charge of the Left Main publications.
In 2013, Dr Morice was designated Best Interventional Cardiologist in France by the French magazine Capital, and in 2014 she received the CHIEN award during ASIA PCR and the Geoffrey O. Hartzler Master Operator Award at TCT 2014 for her career achievements.
Dr. Morice is a member of the executive committee of the Leaders Free, Compare Absorb and Senior trials. She has been a member of the Tokyo Valve Board of Directors since 2016, and of the PCR Clinical Research Course Board of Directors since 2015.
She gave the Gruntzig Lecture during the 2017 Scientific Sessions of the ESC.
Dr. Morice is co-organizer of the ARC HBR initiative
He led WHF’s policy work on cardiovascular and rheumatic heart diseases including successfully spearheading a global campaign for a World Health Assembly Resolution on rheumatic fever and rheumatic heart diseases.
At the WHF, Jeremiah was responsible for managing relationships with the WHO and key public and private sector stakeholders to achieve WHF’s mission and vision. Before joining WHF, Jeremiah represented the American Heart Association (AHA) in Geneva as Global Health Policy Advisor. In this role, he led the AHA’s work in partnering with global health organizations to improve cardiovascular health.
Jeremiah has also worked to support the involvement of patients and the patient voice in health policy making. During his time as Policy and External Affairs Director for the International Alliance of Patients’ Organizations (IAPO), Jeremiah helped strengthen IAPO’s external partnerships with the global health and development community.
Jeremiah holds a Master’s degree in Public Policy, and a BSc in Economics.
Dr Vuyisile Nkomo is an Associate Professor of Medicine and Consultant at the Department of Cardiovascular Diseases, Mayo Clinic and a Director of the Valvular Heart Disease Clinic. His areas of interest include echocardiography and valvular heart disease epidemiology.
Dr. Nkomo received his Doctor of Medicine (MD) degree from Meharry Medical College, Nashville, Tennessee, and completed Internal Medicine and Cardiology Fellowship training at Mayo Clinic, Rochester, Minnesota. He also received his Masters in Public Health (MPH) from the University of Minnesota, Twin Cities, Minnesota, as part of his Cardiology Fellowship.
He is a Fellow of the American College of Cardiology (FACC), a Fellow of the American Society of Echocardiography (FASE) and an American Heart Association (AHA) volunteer expert.
She specialises in echocardiography and in treating patients with valvular heart disease and heart disease during pregnancy. She has presented and published internationally on topics such as valvular heart disease, cardiovascular properties in pregnancy and the role of new technologies in echocardiography, among others.
She was named a Top Doctor by Rhode Island Monthly magazine and has received numerous teaching awards at Brown and Rhode Island Hospital.
With the American College of Cardiology (ACC), Dr. Poppas was the Chair of the ACC Scientific Session ’15 and ’16 and Chair of the ACC Sections Steering Committee 2013-2016. She was Chair of the Governance Committee ’16 – ’19. Previously, she served as governor and chapter president for Rhode Island 2004-2007, chair of the Women in Cardiology Section and member of the Board of Trustees of the American College of Cardiology 2010-2015, among others
Dr. Poppas is a fellow of the American Society of Echocardiography, where she served on committees, including ethics, nominating and scientific programs. She has also worked with American Heart Association and European Society of Cardiology.
She received a Bachelor of Science from Brown University and a Doctor of Medicine from the University of Wisconsin Medical School. Dr. Poppas completed her residencies in internal medicine at University of Wisconsin Hospital and Clinics and fellowship in cardiovascular medicine at University of Chicago Hospital.
Dr Andrew Powell is a Senior Associate in Cardiology at Boston Children’s Hospital, and Professor of Pediatrics at Harvard Medical School.
He graduated from Harvard Medical School in 1992 followed by a residency in pediatrics and fellowship in pediatric cardiology, both at Boston Children’s Hospital. Afterward, he joined the staff there in the Department of Cardiology, where he is currently the Chief of the Cardiac Imaging Division. He is also the current President of the Society for Cardiovascular Magnetic Resonance (SCMR). Dr. Powell specializes in cardiac magnetic resonance imaging and echocardiography.
His research has focused on the development of quantitative MRI methods to guide therapy and predict outcomes of congenital and pediatric heart disease. He has published over 150 research papers, chapters, and review articles.
Véronique L. Roger, MD, MPH graduated from France Medical School and the Minnesota School of Public Health. She is a member of the Association of American Physicians and Professor of Internal Medicine, and Professor of Epidemiology at the Mayo Clinic College of Medicine. She is a cardiologist, epidemiologist, and outcomes researcher. With an interest in the occurrence and outcomes of cardiovascular diseases.
Dr Roger has served on the Mayo Clinic’s Board of Governors and Board of Trustees and was the founding Director of the Robert D. and Patricia E. Kern Center for the Science in Health Care Delivery, which focuses on the science of best practice. She is actively involved in initiatives relevant to the research use of clinical data.
Dr Roger has also served within. the American Heart Association as well as the National Heart, Lung and Blood (NHLBI) of the National Institutes of Health.
Dr Sarano is a Professor of Medicine at the Mayo Clinic College of Medicine with a long-standing interest in valvular heart diseases, outcomes and imaging. He was Director of the Mayo Heart Valve Clinic for over ten years. Dr Sarano’s research has focused on all types of valve diseases from the macroscopic mechanistic point of view to quantitative imaging to outcomes and criteria for intervention with a specific focus on studying the physiology and mechanisms of mitral regurgitation. Over the years, Dr Sarano’s work has provided him with extensive experience in cardiac imaging; leading to the publication of more than 300 peer-reviewed manuscripts related to human cardiac valve disease.
Studied Medicine at University of Bonn, Germany, after having worked as a nurse for 2 years. House officer jobs in Cardiology, Cardiac Surgery and Anaesthetics.
MD thesis on late results after VSD closure in 1988. Initial training in paediatric cardiology in Bonn before research fellowship in cardiac ultrasound at Erasmus University, Rotterdam, NL in 1989. Development of intraoperative epicardial ultrasound and paediatric transoesophageal echocardiography which led to PhD thesis in 1991.
Training in neonatology and paediatric cardiology in Edinburgh and Birmingham, UK. Senior clinical research fellowship in interventional cardiology at Hospital Necker, Paris, France in 1996. Appointment as Consultant Paediatric Cardiologist at Birmingham Children’s Hospital in 1996 (ongoing).
The focus of work shifted more towards interventional catheter across the whole range of congenital heart disease. Development of departmental database system from 1998. Design and build of state-of-the-art biplane catheter theatre and single plane hybrid theatre at BCH in 2010.
Lead in Interventional cardiac catheterisation and hybrid therapies at BCH since 2011. Development and refinement of numerous interventional techniques in the management of the univentricular heart circulation and initial palliation of complex cyanotic congenital heart disease. Senior cardiologist for the complex cardiac surgical program (Norwood/Fontan, AV discordance and PAVSD with MAPCAs).
Ongoing dedicated support to develop congenital heart disease programs in emerging countries.
Alec Vahanian is Emeritus Professor of Cardiology at Université de Paris. He was chairman of the Cardiology department in Bichat Hospital in Paris during the last 20 years.
He is a cardiologist with a main interest in valvular heart disease and interventional cardiology. He pionnered percutaneous mitral commissurotomy in Europe in 1986 and was involved since the early stages in all transcatheter valve intervention on the aortic, mitral and tricuspid valves.
He was the chairman of the ESC Guidelines on Valvular heart disease in 2007and 2012. He was a member of the ESC board until 2018, chairing successively several committees: Clinical Practice Guidelines, Education ,Registries
He authored more than 500 articles in Peer reviewed Journals and is Guest editor of Eurointervention , Associate Editor of European Heart Journal ,editorial consultant for JACC Cardiovascular intervention
He collaborated with “La Chaine de l’ Espoir “ for several years in Maputo and is now involved in the collaboration with Mali.
He has been a pioneer and protagonist of this "cutting edge technology" and has trained numerous surgeons and anaesthesiologists in this field of cardiac surgery around the world.
Dr Murali has 28 years-experience in Cardiothoracic and Vascular Surgery, including 19 years as Chief Cardiothoracic Surgeon. He has performed over 7500 open-heart surgeries with more than 4500 of them on beating heart for coronary artery bypass surgery with a mortality of less than 0.5%. He has only one conversion to the pump in the last 4000 odd OPCAB (Off-Pump Coronary Artery Bypass) surgeries.
Dr Murali has been one of the few surgeons in the world, performing 100 percent of his OPCAB surgeries over the last 10 years without any conversion to the Heart Lung Machine and has performed three Heart transplantations in 2015 of which one of them has survived nearly 3 years - a first of its kind in north Kerala.
Research efforts are targeting the development and
validation of innovative techniques in interventional
medicine including invasive and non-invasive physiological
measurements and imaging, drug-eluting stents and
applications of multi-detector coronary CT angiography.
In addition, ongoing research aims to prevent high-risk
subjects from suffering cardiac disability by modification of
vulnerable plaques and modulation of trigger mechanisms
that precipitate acute events. Professor Wijns is committed
to the development and evaluation of novel device-based
therapies of cardiovascular diseases.
W. Wijns served the European Society of Cardiology (ESC) in
various positions, including Vice-President, Chairman of EU
Affairs, Scientific Program Chair and President of the
European Association of Percutaneous Cardiac Intervention
(EAPCI) of the ESC. Presently, he chairs PCR with focus on
adult learning, knowledge transfer techniques and education
science via Courses and other educational activities
(publishing, web-based learning, seminars and workshops).
Professor Wijns is Associate Editor of the European Heart
Journal, covering acute coronary syndromes, coronary
artery disease and interventional cardiology.
He was appointed consultant cardiologist at the University Hospital of Wales in 2005 where he leads the advanced heart failure and cardiomyopathy programme for South East Wales acting as a referral centre for heart muscle diseases, pulmonary hypertension, metabolic cardiomyopathies, neuro-muscular cardiomyopathies, chemotherapy-cardiomyopathies, and structural inherited cardiac conditions. He has implanted >3,000 biventricular pacing devices, performed >5,000 angiograms/right heart studies, and >150 endocardial cardiac biopsies. He has an interest in the athletic adaptation of the heart and currently sits on the English Football Association cardiac consensus panel.
He has maintained an academic interest, and to date has supervised 7 MD/PhD fellowships and has served as the principal investigator in >35 multi-centre clinical trials, including acting as the UK chief investigator in >5 studies. He has generated academic funds in excess of £1million, authored >100 high impact publications, including co-authorship of a recent publication in the New England Journal of Medicine describing the outcomes of screening adolescent footballer players. He was awarded an honorary chair at Cardiff University in 2018.
He is proud to be a founding member of the pacemaker-reuse task force of the Pan-African Society of Cardiology and regularly participates in pacemaker workshops in developing cardiac centres in Africa. He is keen to share his experiences of cardiac screening for the English Premier league with the African community.